– August 1, 2008
August 1, 2008
View Issues
-
'Active Surveillance' for Low-risk Prostate Cancer
The management options for low-risk prostate cancer include "watchful waiting," or "active surveillance" prior to initiating disease specific treatment. -
Tamoxifen-induced Hot Flushes: The Switch is On
In an open-label cross-over trial of an aromatase inhibitor in early stage post-menopausal breast cancer, patients who had become intolerant of the menopausal symptoms associated with Tamoxifen improved in this regard by switching to an aromatase inhibitor (AI). -
The Epidemiology of MDS and Myeloproliferative Disorders
Epidemiologic data have recently become available in the U.S. for myelodysplastic syndromes (MDS), chronic myeloproliferative disorders (CMD) and chronic myelomonocytic leukemia (CMML) after registries began including these conditions in 2001. -
The Role for PET Scanning in Breast Cancer Staging
The role for PET scanning is not yet established for the staging of newly-diagnosed breast cancer or for patients in whom recurrent disease is suspected. -
Pharmacology Watch
Baxter Bioscience has developed a whole-virus, two dose vaccine against avian flu; warning label now on antipsychotics regarding an increased risk of mortality in elderly patients treated for dementia-related psychosis; vitamin D for men with heart disease on horizon? A new oral anticoagulant may soon be available for prevention of thrombotic complications of hip or knee surgery; FDA Actions -
Clinical Briefs in Primary Care supplement